These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29601936)

  • 1. Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Castillo B; Vera N; Ortega-Loayza AG; Seminario-Vidal L
    J Am Acad Dermatol; 2018 Oct; 79(4):764-767.e1. PubMed ID: 29601936
    [No Abstract]   [Full Text] [Related]  

  • 2. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Treat J
    Pediatr Ann; 2010 Oct; 39(10):667-9, 672-4. PubMed ID: 20954613
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical treatment protocol for Stevens-Johnson syndrome and toxic epidermal necrolysis: a brief report.
    Evans J
    J Wound Ostomy Continence Nurs; 2009; 36(5):509-11. PubMed ID: 19752660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey.
    Curtis JA; Christensen LC; Paine AR; Collins Brummer G; Summers EM; Cochran AL; Petersen MJ; Hull CM
    J Am Acad Dermatol; 2016 Feb; 74(2):379-80. PubMed ID: 26775781
    [No Abstract]   [Full Text] [Related]  

  • 6. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management.
    Mockenhaupt M
    Semin Cutan Med Surg; 2014 Mar; 33(1):10-6. PubMed ID: 25037254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JK; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KM; Wong GA; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    Br J Dermatol; 2016 Jun; 174(6):1194-227. PubMed ID: 27317286
    [No Abstract]   [Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulins for delayed wound healing associated with toxic epidermal necrolysis.
    Dequidt L; Darrigade AS; Camus T; Taieb A; Milpied B
    Eur J Dermatol; 2019 Apr; 29(2):229-231. PubMed ID: 30983592
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of toxic epidermal necrolysis.
    Craven NM
    Hosp Med; 2000 Nov; 61(11):778-81. PubMed ID: 11198746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.
    Trubiano JA; Redwood A; Strautins K; Pavlos R; Woolnough E; Chang CC; Phillips E
    J Allergy Clin Immunol Pract; 2017; 5(3):823-826. PubMed ID: 27888029
    [No Abstract]   [Full Text] [Related]  

  • 15. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
    Watanabe H; Iijima M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of toxic epidermal necrolysis in a 15-year-old girl.
    Clennett S; Hosking G
    J Wound Care; 2003 Apr; 12(4):151-4. PubMed ID: 12715488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Kühn-Córdova I; Ramírez-Bouchan D; Gamboa-Marrufo JD
    An Pediatr (Barc); 2007 Jul; 67(1):68-73. PubMed ID: 17663910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostication Using SCORTEN Severity of Illness Score in Patients With Stevens Johnson Syndrome and Toxic Epidermal Necrolysis.
    Seecof OM; Liantonio J
    J Pain Symptom Manage; 2019 Jan; 57(1):e8-e9. PubMed ID: 30273718
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous immunoglobulin for treatment of toxic epidermal necrolysis.
    Nasser M; Bitterman-Deutsch O; Nassar F
    Am J Med Sci; 2005 Feb; 329(2):95-8. PubMed ID: 15711426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.